Vitamin D Metabolites and Binding Protein Predict Preeclampsia in Women with Type 1 Diabetes

The risk for preeclampsia (PE) is enhanced ~4-fold by the presence of maternal type 1 diabetes (T1DM). Vitamin D is essential for healthy pregnancy. We assessed the total, bioavailable, and free concentrations of plasma 25-hydroxyvitamin D (25(OH)D), 1,25-dihydroxyvitamin D (1,25(OH) D), and vitamin D binding protein (VDBP) at ~12, ~22, and ~32 weeks' gestation ("Visits" (V) 1, 2, and 3, respectively) in 23 T1DM women who developed PE, 24 who remained normotensive, and 19 non-diabetic, normotensive women (reference controls). 25(OH)D deficiency was more frequent in diabetic than non-diabetic women (69% vs. 22%, < 0.05), but no measure of 25(OH)D predicted PE. By contrast, higher 1,25(OH) D concentrations at V2 (total, bioavailable, and free: < 0.01) and V3 (bioavailable: < 0.05; free: < 0.01), lower concentrations of VDBP at V3 ( < 0.05), and elevated ratios of 1,25(OH) D/VDBP (V2, V3: < 0.01) and 1,25(OH) D/25(OH)D (V3, < 0.05) were all associated with PE, and significance persisted in multivariate analyses. In summary, in women with T1DM, concentrations of 1,25(OH) D were higher, and VDBP lower, in the second and third trimesters in women who later developed PE than in those who did not. 1,25(OH) D may serve as a new marker for PE risk and could be implicated in pathogenesis.